Form 4: Insuleet Corp CEO James Hollingshead Reports Stock Transaction

James Hollingshead, President and CEO of Insulet Corp, reports a transaction involving common stock related to tax obligations from vesting restricted stock units.

Summary

• On February 28, 2025, James Hollingshead, the President and CEO of Insulet Corporation, reported a transaction involving the company's common stock.
• The transaction involved the withholding of 1,160 shares to cover tax obligations associated with the vesting of restricted stock units.
• The price per share for the transaction was $272.27.
• Following the transaction, Hollingshead directly owns 64,834 shares of Insulet Corp common stock.

Sentiment

Score: 5

Explanation: This is a neutral filing related to a routine stock transaction for tax purposes. It doesn't indicate positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the company's outlook or performance.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders and are required by the SEC.
• The transaction described is typical for executives receiving stock-based compensation, as they often need to cover tax liabilities upon vesting.
• Comparable companies such as Dexcom (DXCM) and Abbott (ABT), also have similar filings related to their executives' stock transactions.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it is related to tax obligations of an executive.
• The filing provides transparency regarding executive stock ownership, which can be of interest to shareholders.

Key Dates